Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9437 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.9301 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.9184 |
High Similarity |
NPD7411 |
Suspended |
0.9014 |
High Similarity |
NPD1549 |
Phase 2 |
0.9007 |
High Similarity |
NPD7075 |
Discontinued |
0.8993 |
High Similarity |
NPD6801 |
Discontinued |
0.8944 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8944 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8936 |
High Similarity |
NPD1510 |
Phase 2 |
0.8933 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8933 |
High Similarity |
NPD7819 |
Suspended |
0.8921 |
High Similarity |
NPD1240 |
Approved |
0.8873 |
High Similarity |
NPD2796 |
Approved |
0.8836 |
High Similarity |
NPD6799 |
Approved |
0.8819 |
High Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8794 |
High Similarity |
NPD1607 |
Approved |
0.8759 |
High Similarity |
NPD3750 |
Approved |
0.8733 |
High Similarity |
NPD4380 |
Phase 2 |
0.8693 |
High Similarity |
NPD7768 |
Phase 2 |
0.8684 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8662 |
High Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8627 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8609 |
High Similarity |
NPD6599 |
Discontinued |
0.8562 |
High Similarity |
NPD1243 |
Approved |
0.8516 |
High Similarity |
NPD3749 |
Approved |
0.8516 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8511 |
High Similarity |
NPD2313 |
Discontinued |
0.8511 |
High Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8493 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8483 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8483 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8456 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8442 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8414 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.8414 |
Intermediate Similarity |
NPD3748 |
Approved |
0.8411 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8411 |
Intermediate Similarity |
NPD920 |
Approved |
0.8389 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.8387 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8377 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8344 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8311 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8286 |
Intermediate Similarity |
NPD1203 |
Approved |
0.8282 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.8278 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.8278 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8278 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8278 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8278 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8276 |
Intermediate Similarity |
NPD6651 |
Approved |
0.8272 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8272 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.8255 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8217 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8187 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8163 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.8148 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8125 |
Intermediate Similarity |
NPD3268 |
Approved |
0.8125 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8112 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.8101 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8098 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8082 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.8082 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.8071 |
Intermediate Similarity |
NPD9717 |
Approved |
0.8065 |
Intermediate Similarity |
NPD3226 |
Approved |
0.8054 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.8041 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.8038 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8028 |
Intermediate Similarity |
NPD2797 |
Approved |
0.8013 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.8013 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.8012 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.8 |
Intermediate Similarity |
NPD919 |
Approved |
0.7975 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7975 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7975 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7964 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.795 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7939 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7939 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7933 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7892 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7892 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7857 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7847 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7844 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7832 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7829 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.78 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7798 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7785 |
Intermediate Similarity |
NPD6585 |
Discontinued |
0.7778 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7778 |
Intermediate Similarity |
NPD3266 |
Approved |
0.777 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7755 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7751 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7748 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7748 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7746 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7736 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7736 |
Intermediate Similarity |
NPD5889 |
Approved |
0.7736 |
Intermediate Similarity |
NPD5890 |
Approved |
0.7727 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7718 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7714 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7714 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7707 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7702 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7698 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7651 |
Intermediate Similarity |
NPD943 |
Approved |
0.7643 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.764 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7636 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7636 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7635 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7635 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7633 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7632 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7632 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7632 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7632 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7619 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.761 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.76 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7586 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7582 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7576 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7569 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7548 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7534 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7517 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7517 |
Intermediate Similarity |
NPD411 |
Approved |
0.7516 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7514 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7514 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD2354 |
Approved |
0.75 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7484 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7483 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7483 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7483 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7472 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7472 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7471 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7468 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.745 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7448 |
Intermediate Similarity |
NPD3972 |
Approved |
0.744 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7425 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7405 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7389 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7361 |
Intermediate Similarity |
NPD17 |
Approved |
0.7355 |
Intermediate Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.7355 |
Intermediate Similarity |
NPD2353 |
Approved |
0.7353 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7351 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7343 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.7329 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7299 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7299 |
Intermediate Similarity |
NPD8313 |
Approved |
0.729 |
Intermediate Similarity |
NPD4476 |
Approved |
0.729 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7289 |
Intermediate Similarity |
NPD6971 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7267 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7262 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7261 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.726 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7255 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7251 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7244 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7244 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7244 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7244 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7244 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7237 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7234 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7233 |
Intermediate Similarity |
NPD7440 |
Discontinued |
0.7213 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7205 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7191 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.719 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7184 |
Intermediate Similarity |
NPD6104 |
Discontinued |
0.7181 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7176 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7172 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.7169 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7163 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7162 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7152 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7151 |
Intermediate Similarity |
NPD5940 |
Clinical (unspecified phase) |
0.7151 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7134 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7134
|
Intermediate Similarity |
NPD6502 |
Phase 2 |